Dogs with Mammary Gland Tumors and the Feeding Dietary Types
World Small Animal Veterinary Association World Congress Proceedings, 2003
S. Sirivaidyapong
Department of Obstetrics, Gynaecology and Reproduction, Faculty of Veterinary Science, Chulalongkorn University Bangkok
Bangkok, Thailand

Objectives

Canine mammary tumor has been used as a model for human breast cancer in several clinical trials. Influenced factors of the tumor include steroid receptors and Growth hormone. Dietary, one of associated factors, has been suggested that might be of etiologic importance in canine mammary tumor but still has insufficient information. Present study aimed to specifically investigate the relation of dietary types frequently fed to dogs with and without mammary tumor.

Materials & Methods

The study was organized during 2001-2002 in Bangkok by interviewing the owners of 275 dogs (2.6-15 years old) diagnosed with mammary gland tumors and the owners of 150 non-tumor dogs (3.3-18 years old). All dogs in the study were intact (non-spayed) female.

Results

Data showed that 91.3 % from the dogs with mammary tumor had been fed with homemade diet (31.6% fat, 40.4% carbohydrate and 24.9% protein) and only 0.7 % strictly fed with commercial dry diet (13.0% fat, 54.5% carbohydrate and 21.5% protein). In contrast, in the non-tumor dogs, only 10% had been fed with homemade diet and 56 % strictly fed with commercial dry diet.

Conclusion

High fat homemade diet found to involve in or play a critical role on canine mammary gland tumor reported in human breast cancer.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

S. Sirivaidyapong
Department of Obstetrics, Gynaecology and Reproduction
Faculty of Veterinary Science
Chulalongkorn University Bangkok
Bangkok, Thailand


MAIN : Oncology : Mammary Gland Tumors
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27